GlycoMimetics’ Uproleselan: Navigating Clinical And Financial Complexities In AML (GLYC)
PM Photographs At a Look GlycoMimetics' (NASDAQ:GLYC) uproleselan, focusing on acute myeloid leukemia (AML), notably in its difficult relapsed/refractory types, ...
